Kim, Y., Apetri, M., Luo, B., Settleman, J. E., & Anderson, K. S. (2015). Differential Effects of Tyrosine Kinase Inhibitors on Normal and Oncogenic EGFR Signaling and Downstream Effectors. Mol Cancer Res.
Chicago-tyylinen lähdeviittausKim, Youngjoo, Mihaela Apetri, BeiBei Luo, Jeffrey E. Settleman, ja Karen S. Anderson. "Differential Effects of Tyrosine Kinase Inhibitors On Normal and Oncogenic EGFR Signaling and Downstream Effectors." Mol Cancer Res 2015.
MLA-viiteKim, Youngjoo, et al. "Differential Effects of Tyrosine Kinase Inhibitors On Normal and Oncogenic EGFR Signaling and Downstream Effectors." Mol Cancer Res 2015.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.